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Abstract
Objective: To determine the antibiotic susceptibility of K. pneumoniae isolates from Buea, Cameroon. 
Design: A prospective study of K. pneumoniae isolates from clinical samples of nosocomial origin. 
Setting: A laboratory based investigative study at the Biotechnology Centres of the Universities of Buea and 
Yaounde 1, Cameroon, and three Buea based hospitals. K. pneumoniae isolates were obtained from sputum, 
wound swabs and urine and screened for their antibiogram using standard procedures.
Results: Results on the antibiogram showed seven distinct antibiotypes distinguished by different susceptibilities 
to aminoglycosides (Spectinomycin and Gentamicin), Chloramphenicol and Augmentin. All the isolates 
shared multi-resistance to Amoxicillin and Trimethoprim. However, the isolates showed marked susceptibilities 
to Norfloxacin (90.01%), Cefuroxime (95.45%) and Ciprofloxacin (86.36%).
Conclusion: The study has revealed that K. pneumoniae isolates in the environment of Buea, Cameroon are 
multi-drug resistant. This finding is of clinical and epidemiological significance.
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Introduction
Klebsiella pneumoniae is an important human pathogen 
that has been associated in recent decades with nosocomial 
outbreaks.12They are important opportunistic pathogens, 
commonly isolated from urinary tract infections, surgical 
wounds, nosocomial pneumonia and bloodstream 
infections.3,4 These organisms are also an important source 
of transferable antibiotic resistance, and several outbreaks 
caused by multiple resistant K. pneumoniae, especially the 
extended-spectrum B-lactamase-producing(ESBL) strains 
of the types TEM and SHV have been reported.5‘K 
, Owing to their clinical significance, many methods exist 
for the epidemiological investigation of infections caused 
by this organism. In different parts of the world, biotyping, 
serotyping, antibiogram, plasmid profiles and more recent 
techniques like pulse field gel electrophoresis (PFGE) and 
random amplified polymorphic deoxyribonucleic acid 
(RAPD) analyses have been used in typingKlebsiellae.'1'12
In the present study, we decided to use antibiogram as an 
epidemiological marker for if. pneumoniae isolates because 
there is a high frequency of drug abuse in the environment 
of Buea, Cameroon. The penicillins, Chloramphenicol, 
and to a lesser extent the aminoglycosides are relatively 
cheap, and therefore commonly available to the population;
who tend to abuse them, heralding the emergence of 
resistance.13
K. pneumoniae are known to be resistant to a number of 
antibiotics, including extended-spectrum cephalosporins 
and aminoglycosides, because of the acquisition of plasmids 
which code for the production of ESBL and aminoglycoside­
modifying enzymes.1014 However, it has been widely 
acclaimed that the susceptibility of pathogens to antibiotics 
varies with time and geographical location.15-1(1 Since they 
account for a significant proportion of nosocomial infections 
and the tendency of nosocomial pathogens to develop or 
acquire new antibiotic resistance traits poses a great problem 
in their treatment and control,1‘4'1(117it becomes necessary, 
therefore, to study the susceptibility patterns of K. 
pneumoniae isolates to some commonly used and relatively 
reserved antibiotics in Cameroon in order to update our 
knowledge on the use of these antimicrobial agents in the 
management of K. pneumoniae infections.
In Buea, Cameroon, there appears to be no report on the 
antibiogram and epidemiology of AT. pneumoniae infections. 
In fact, we are not aware of any. It is against this background 
that the antibiogram of K. pneumoniae isolates was 
determined in an attempt to provide baseline data for 
clinical management and epidemiological surveys.
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Materials and Methods
Setting and Patients.
During a period of five months; April to August 2000, a 
total of 105 specimens comprising sputum, wound swabs, 
and urine were collected from hospitalised patients at the 
following medical centres in Buea, Cameroon; Buea District 
Hospital, Mount Mary Hospital and the Military Hospital. 
The patients included both males and females of all age 
groups. Infection due to K. pneumoniae was considered 
nosocomial if it appeared within 48 hours after admission 
according to the criteria of the Centers for Disease Control 
and Prevention.18 
Bacterial Isolates.
Specimens (sputum, wound swabs and urine) were 
inoculated onto Eosin methylene blue agar (EMB) and 
MacConkey agar plates (MCA). Urine specimens were in 
addition inoculated onto cystein lactose electrolyte deficient 
(CLED) agar plates. The inoculated plates were incubated 
at 37°C for 24 hours, after which characteristic colonies 
were observed. Suspicious colonies were then sub-cultured 
on fresh EMB, CLED or MCA plates to obtain pure 
cultures19 for further identification. Isolates were identified 
as K. pneumoniae by subjecting them to the API 20E 
(BioMerieux SA, France) screening Kit according to the 
manufacturer’s instructions.
Antibiotic Susceptibility Testing.
The Kirby-Bauer disk diffusion test, which conforms to 
the recommended standard of the National Committee for 
Clinical Laboratory Standards (NCCLS),20 was used as 
previously described.21 Briefly, a small inoculum of each 
pure bacterial isolate was emulsified in 3ml sterile normal 
saline in Bijou bottles and the density compared to a 
barium chloride standard (0.5McFarland). A sterile cotton 
swab was dipped into the standardized solution of bacterial 
cultures and used to evenly inoculate Muller-Hinton plates 
(Biotec, England) and allowed to dry. Thereafter, antibiotic 
disks with the following drug contents — Amoxicillin 
(10p,g); Gentam icin (lO pg); Cefuroxime (30p,g); 
Augmentin (30pg); Spectinomycin (30pg); Ofloxacin 
(5pg); Chloramphenicol (lOpg); Ciprofloxacin (5pg); 
Norfloxacin (lOpg) and Trimethoprim (5pg), (Oxoid, 
England) were placed on the plates, spacing them well to 
prevent the overlapping of inhibition zones. The plates 
were incubated at 37°c for 24 hours and the diameters were 
then compared with recorded diameters of the control 
organism, E. coli ATCC 25922 to determine susceptibility 
or resistance.8,16,22
Results
Antimicrobial Susceptibility Patterns.
Table I shows the antimicrobial Susceptibility results 
exhibited by K. pneumoniae isolates. Of the 22 isolates 
tested, over 85% were sensitive to the fluoroquinolones 
(Norfloxacin, C iprofloxacin, Ofloxacin) and the 
Cephalosporin, Cefuroxime. Most strains showed varied
susceptibilities to the Aminoglycosides (Gentamicin and 
Spectinomycin), Augmentin and Chloramphenicol. 
However, all isolates showed total resistance (100%) to 
Amoxicillin and Trimethoprim. K. pneumoniae isolates 
were identified as belonging to seven different antibiotypes 
(Table II) distinguished by different susceptibilities to 
Aminoglycosides, Chloramphenicol and Augmentin. Most 
of the isolates (77.3%) were resistant to three or more 
antibiotics. The predominant antibiotype (AmxR, TmpR) 
constituted nine (40.91%) of the isolates while the least 
patterns (AmxR, TmpR AugR) and (AmxR, TmpR,ChlR AugR, 
GenR, SpcR) were exhibited by one (4.54%) isolate 
respectively.
Table I: Antibiotic sensitivity results ofK. pneumoniae 
strains isolated from various clinical specimens.
Antibiotics Susceptible (%) Resistant (%)
Trimethoprim (5pg) 0 (0%) 22 (100%)
Norfloxacin (10pg) 20 (90.01%) 2 (9.09%)
Ciprofloxacin (5pg) 19 (86.36%) 3 (13.64%)
Gentamicin (10pg) 17 (77.27%) 5 (22.73%)
Cefuroxime (30pg) 21 (95.45%) 1 (4.54%)
Augmentin (30pg) 14 (63.64%) 8 (36.36%)
Amoxicillin (10pg) 0 22 (100%)
Ofloxacin (5pg) 21 (95.45%) 1 (4.54%)
Chloramphenicol (10pg) 13 (59.09%) 9(40.91%)
Spectinomicin (30pg) 18(81.82%) 4(18.18%)
Table II: Antibiotypes ofK. pneumoniae isolates.
Antibiotype"
Number of
strains with antibiotype
% with 
antibiotype
AmxR, Tmp" 9 40.91%
Amx", Tmp", SpcR 3 13.64%
AmxR, TmpR, Chi" 2 9.09%
Amx", Tmp", Chi", Aug" 2 9.09%
Amx", Tmp", Gen", Chi",.Aug" 4 18.18%
Amx", Tmp", Chi” Aug", Gen", Spc" T 4.54%
Amx", Tmp", Aug" 1 .4,54%
‘Abreviations: Amx— Amoxicillin; Tmp —  Trimethoprim; spc—  
Spectinomicin; Chi- Cloramphenicol; Aug — Augmntin; Gen —  Gentamicin. 
"Resistance.
Discussion
K. pneumoniae accounts for a substantial degree of 
nosocomial infections1,2 and the increasing tendency for 
nosocomial pathogens to acquire new antibiotic resistance 
traits poses a problem in chemotherapy10,17,23 revealing the ■ 
need for an updated antibiotic susceptibility pattern for the 
effective management of infections caused by these 
organisms. This study reports on the antibiogram of K. 
pneumoniae. Results revealed that K. pneumoniae isolates 
showed marked susceptibilities to Ciprofloxacin, 
Norfloxacin, Ofloxacin, Cefuroxime and Gentamicin 
(Table I). The extreme susceptibility (95.45%)Ao the 
cephalosporin, Cefuroxime; the quinolones, Ofloxacin 
(95.45%), Norfloxacin (90.10%) and Ciprofloxacin
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(86.36%); the aminoglycosides, Spectinomycin (81.82%) 
and Gentamicin (77.27%) is at variance with those of other 
investigators.1'2’4,10'24'25
Though one isolate in this study showed4 low levels of 
susceptibilities to these drugs, the others documented 
extreme resistance to them, which they attributed to the 
production of ESBL. We speculate that the observed 
unusual difference could be related to the limited use of 
these drugs in Cameroon due to their high costs, therefore 
limiting the selection of resistant mutants. This could be 
further supported by the fact that previous studies have 
reported a wide distribution of these enzymes with the 
TEM-3 more prevalent in Europe, TEM-1Q, TEM-12 and 
TEM-26 in the USA, SHV-2 and SHV-5 world wide 
except sub-Saharan Africa.26
Until recently when it was reported in South Africa,22 
these enzymes had been isolated from the Saharan African 
countries of Tunisia and Egypt.27 On the other hand, we are 
constrained to speculate that the non determination of 
ESBL production in our strains may be a contributing 
factor to this unusual susceptibility, especially to the 
cephalosporins, because production of G-lactamases is 
known to cause hidden resistance to the expanded-spectrum 
cephalosporins.28 Lower levels of susceptibility to 
Augmentin (63.64%) and Chloramphenicol (59.09%) were 
also observed corroborating a previous finding,4 even 
though a high degree of susceptibility (>80%) of the 
Klebsiellae to Chloramphenicol and Augmentin had been 
documented.29 This could be linked to the fact that 
Chloramphenicol, commonly used in our environment to 
treat typhoid fever, is highly abused13 thus putting a selective 
pressure on the drug, hence the emergence of resistance to 
i t .
Results of this study revealed seven distinct resistance 
patterns (antibiotypes), of which the most prevalent 
exhibited resistance to Amoxicillin and Trimethoprim 
(AmxR, TmpR) accounting for 40.91% of the isolates 
(Table II). This is also in agreement with the findings of 
Livrelli et al.4 The least patterns (AmxR, Tmp, ChlR, AugR, 
GenR, SpcR) and (AmxR, TmpR, AugR) were exhibited by 
one (4.55%) isolate respectively. All the antibiotypes 
shared resistance to Amoxicillin and Trimethoprim. This 
suggests that these drugs may not be useful in the treatment 
of K. pneumoniae infections in this area.
An interesting feature pf this study is that all K. 
pneumoniae isolates were resistant to two or more 
antibiotics. The multiple resistance to these drugs could be 
attributed to the fact that these antibiotics are highly 
abused due to constant and indiscriminate usage.13 Also, 
Klebsiellae are known to be an important source of 
transferable antibiotic resistance among Gram-negative 
bacilli.5'8’30 Consequently, the occurrence of multiply 
resistant Klebsiella strains might pose a potential problem 
in the treatment of infections in the study area.
With the use of an antibiogram, this study has provided 
baseline data for epidemiological research on K. 
-pneumoniae infections in the environment of Buea, 
Cameroon. We, however, suggest the need to adopt
discriminatory molecular typing methods such as RAPD 
and PFGE to complement the typing of K  pneumoniae 
isolates in our environment.
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